Lipid formulations of amphotericin B for empirical treatment of fever and neutropenia.
Publication
, Journal Article
Frothingham, R
Published in: Clin Infect Dis
October 1, 2002
Duke Scholars
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
October 1, 2002
Volume
35
Issue
7
Start / End Page
896 / 897
Location
United States
Related Subject Headings
- Neutropenia
- Microbiology
- Lipids
- Humans
- Fever
- Clinical Trials as Topic
- Chemistry, Pharmaceutical
- Antifungal Agents
- Amphotericin B
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Frothingham, R. (2002). Lipid formulations of amphotericin B for empirical treatment of fever and neutropenia. Clin Infect Dis, 35(7), 896–897. https://doi.org/10.1086/342564
Frothingham, Richard. “Lipid formulations of amphotericin B for empirical treatment of fever and neutropenia.” Clin Infect Dis 35, no. 7 (October 1, 2002): 896–97. https://doi.org/10.1086/342564.
Frothingham R. Lipid formulations of amphotericin B for empirical treatment of fever and neutropenia. Clin Infect Dis. 2002 Oct 1;35(7):896–7.
Frothingham, Richard. “Lipid formulations of amphotericin B for empirical treatment of fever and neutropenia.” Clin Infect Dis, vol. 35, no. 7, Oct. 2002, pp. 896–97. Pubmed, doi:10.1086/342564.
Frothingham R. Lipid formulations of amphotericin B for empirical treatment of fever and neutropenia. Clin Infect Dis. 2002 Oct 1;35(7):896–897.
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
October 1, 2002
Volume
35
Issue
7
Start / End Page
896 / 897
Location
United States
Related Subject Headings
- Neutropenia
- Microbiology
- Lipids
- Humans
- Fever
- Clinical Trials as Topic
- Chemistry, Pharmaceutical
- Antifungal Agents
- Amphotericin B
- 3202 Clinical sciences